In light of recent global shocks and rising external volatility, there is a growing need to effectively monitor short-term economic fluctuations, especially in countries with limited access to ...

Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...

The models are designed to predict someone’s risk of diabetes or stroke. A few might already have been used on patients.

We need investment in precision medicine technologies to start programming cancer against itself, writes Cyriac Roeding.

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.

A massive Swedish study shows that AI can spot people at higher risk of melanoma using routine health data. Advanced models ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Now Jordan’s books are getting a new lease on life. Several new leases, actually. The series ...

Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of ...

Seventy-one percent of counties that spray the most glyphosate have late-stage non-Hodgkin lymphoma incidence rates above the national average, according to a new data analysis from the advocacy group ...

Real-world data show ADCs benefit more diverse, older and pretreated patients, helping guide care and build confidence beyond ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...